Free Webinars offered by PELOBiotech.

PELOQuoi? Votre expert pour la culture cellulaire, PELOBiotech

présenté par Dr. Gautier Arista, International Sales, PELOBiotech GmbH, Allemagne

Si vous ne connaissez pas PELOBiotech, joignez-vous à nous pour découvrir nos activités. Comme mise en bouche, sachez que nous sommes experts en culture cellulaire. Nous nous focalisons sur les cellules primaires et milieux de culture. Mais pas que, comme vous pourrez le constater en voyant notre large portfolio et autres services.

Vous connaissez déjà notre entreprise ? N’hésitez pas à venir dire bonjour, poser vos questions et découvrir nos plus récents partenaires et collaborateurs.

Le séminaire sera présenté par Dr. Gautier Arista, belge d’origine, travaillant maintenant à Munich chez PELOBiotech au niveau des ventes internationales. Vous pouvez vous enregistrer en suivant le lien ci-après.

language: French

Powerful predictive 3D models through improved statistics and enhanced physiological accuracy

presented by Dr. Marco Leu, COO abc biopply, Switzerland

Multi-organoid in chip technology – Explore the transformative potential of our multi-organoid in chip technology. This groundbreaking innovation has the potential to revolutionize drug development by providing more accurate preclinical disease models, resulting in increased efficacy.

Secure your spot  by sending an email to marco.leu@abcbiopply.com

EMERGE Episode 10  |
Trapped ion mobility-resolved (phospho)proteomics of clinical samples

presented by Florian Meier, Jena University Hospital, and ReSyn Biosciences, Southafrica

This presentation will showcase applications of dia-PASEF to analyze the proteome and phosphoproteome of clinical samples with high throughput and high sensitivity.

EMERGE Episode 9 | Serial proteome profiling in human and animal cardiac tissues by data-independent acquisition mass spectrometry (DIA-MS)

presented by Dr. Christof Lenz, University of Göttingen and ReSyn Biosciences, Southafrica

Due to the inherent challenges in obtaining samples, biomolecular cardiovascular research has often relied on cellular or animal model.

EMERGE Episode 10  |
Trapped ion mobility-resolved (phospho)proteomics of clinical samples

presented by Florian Meier, Jena University Hospital, and ReSyn Biosciences, Southafrica

This presentation will showcase applications of dia-PASEF to analyze the proteome and phosphoproteome of clinical samples with high throughput and high sensitivity.

EMERGE Episode 9 | Serial proteome profiling in human and animal cardiac tissues by data-independent acquisition mass spectrometry (DIA-MS)

presented by Dr. Christof Lenz, University of Göttingen and ReSyn Biosciences, Southafrica

Due to the inherent challenges in obtaining samples, biomolecular cardiovascular research has often relied on cellular or animal model.

PELOAcademy | Glaucoma - One Step Ahead with In-vitro Models

presented by Tommaso Sbrana, CEO IVtech, Italy

Glaucoma is a neurodegenerative disease characterized by optic nerve damage and the slow progressive death of retinal ganglion cells (RGCs). At the
early stage, this pathology is almost asymptomatic but, over time, it affects the peripheral and then the central vision, leading to progressive and irreversible blindness.

Islet Viability and Potency Testing

presented by Klearchos K Papas, Institute for Cellular Transplantation, University of Arizona, Cell Transplant and Regenerative Medicine Society

The challenge for all laboratories manufacturing islets for potential transplantation is what menu of the tests available to assess islet viability and potency. Can they meet the standards specified by the FDA regulations above? Where do these methods fall short? The webinar will review the current state of the art and note areas for future development.

Challenges of Recovering Islets from Chronic Pancreatitis Patients

Presented by Gopalakrishnan Loganathan, Ph.D.​​​​​​​​​​​, University of Louisville, USA

Islet yield is the critical factor for the success of autologous islet transplantation. The higher the islet yield, the higher probability of the recipient will have an easier time managing iatrogenic diabetes created by this procedure.

PELOAcademy: The Ultimate Lebkuchen 101 / Aus Lothars Geheimen Rezeptbüchern

Presented by Dr. Lothar Steeb , CEO & CSO PELOBiotech

Workflow-Series: The Ultimate Lebkuchen 101. Enjoy on this festivity: Lothar will tell you about his family's secret Lebkuchen recipe – but only a little bit :-)-.

Workflow-Series: Can Cell Culture be as good as in vivo today?
Part 7 Tissue & Cell-Sourcing

Presented by Dr. Peter Frost, CEO PELOBiotech

Watch on demand in German

Overcoming the Challenges of Low Islet Recovery from Young Organ Donors

Presented by Balamurugan N. Appakalai, Ph.D. Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, US

Human islet isolation from young donors is problematic. Application of standard islet isolation methods to donor pancreata less than 32 years old (YO) often results in low islet recovery. Low recovery reflects the ineffectiveness of current methods to separate the islets from acinar tissue, leading to high percentages of mantled/embedded islets.

Workflow-Series: Can Cell Culture be as good as in vivo today? Advanced Defined Media for MSCs
Part 6

Presented by Dr. Peter Frost, CEO PELOBiotech

Watch on demand in German

3D Series: A new standard in 3D Cell Culture – 3D CoSeedis™ Chips

Presented by Marco Leu, Ph. D., abc biopply

With the 3D CoSeedis™ Chip family of products, abc biopply set new standards in 3D cell culture. The chips are designed to offer an optimum of flexibility in terms of throughput and compatibility to numerous applications.

New Products: Bright future ahead – Unique Imaging Reagents and Advanced Cell Culture Products

Presented by Kota Kumazawa, Funakoshi, Tokyo, Japan

Are you satisfied with your current imaging reagents? Get better images and new insights by our new imaging reagents, developed by the latest technologies.
And make your cell and cell culture life comfortable by unique consumables.

Webinar-Series Workflow: Can Cell Culture be as good as in vivo? 2D/3D Cell Culture
Part 5

presented by Dr. Peter Frost, CEO, PELOBiotech

In the last 10 years Dr. Peter Frost was involved in 3D Cell Culture doing mainly business development for techniques like liquid overlay, magnetic spheroid formation, hanging drop technology and others.

Watch on demand in German

Disease-relevant In-vitro Models of Pre-metastatic Tissue Microenvironments

Presented by Evelyn Aranda, PhD, Senior Scientist, Xylyx Bio, New York, US

Dissemination of cancer cells is a process that results in tissue-specific homing to distant organs, being bone, liver, and lung the most common sites of metastasis.

Enabling HTS (phoshpo)proteomics using High Capacity Magnetic Microparticles

Presented by Stoyan Stoychev (PhD) Head of Proteomics, ReSyn Biosciences, Southafrica

The requirement for robust and routine high-throughput sample preparation methods has become a necessity as proteomics reaches maturity.

Workflow-Series: Can Cell Culture be as good as in vivo? Serum- & Xeno-free Cell Culture Media
Part 4

Presented by Dr. Lothar Steeb, CSO, PELOBiotech

Watch on demand in German

Let Cells do the Work: New Approaches to 3D Culture Models

presented by Dr. med Andreas Thomsen, University Medical Center Freiburg, Dept. of Radiation Oncology

This webinar is meant to inspire your experimental models and provide novel insights into tissue-specific interaction of cells. The novel scaffold-free 3D cell co-culture system 3D CoSeedisTM consists of a unique conical agarose matrix array (CAMA) that allows the formation of spheroidal and non-spheroidal cell aggregates in a highly-reproducible and consistent manner.

3D Cell Cultures: State-of-the-art, New Solutions and Advanced Applications

Presented by James T. Shoemaker, Chief Science Officer, Lena Biosciences

In this webinar, attendees will learn about the advantages of 3D cell culture and how the tools developed by Lena Biosciences can enable researchers to create cutting-edge tissue models applicable to all areas of biomedical research. Tissue models discussed will include: brain, breast cancer, lung cancer, and liver (both for drug metabolism and as a platform for viral infection).

Series Workflow: Can Cell Culture be as good as in vivo? Cell Seeding and Cell Culture Environment
Part: 3

Presented by Dr. Lothar Steeb, CSO, PELOBiotech

Watch on demand in German

Highly Homogenous 384-well Compatible 3D Cell Culture for HTS Applications

Presented by Marco Leu, PhD, abc biopply

Highly Homogenous 384-well Compatible 3D Cell Cultures for High-Throughput screening application.

Webinar-Series Workflow: Can Cell Culture be as good as in vivo?
Part: 2 Tissue Isolation & Cell Viability

Presented by Dr. Lothar Steeb, CSO, PELOBiotech

Watch on demand in German

5Ds in-vitro Models: Material & Methods to Increase the Correlation with Human Reality

Presented by Tommaso Sbrana, CEO IVtech, Italy

In-vitro cell cultures are often proposed as “Alternatives” to animal models, but they are still inadequate to reproduce the human pathophysiology. This is mainly due to the technological limitations of the standard equipment used in cell culture laboratories, such as the lack of a 3D micro-architecture, the static environment and the absence of cross talk between different tissues.

New Products: Physiologically Predictive Tools for Static and Dynamic 3D Cell Culture

Presented by James T. Shoemaker, CSO Lena Biosciences

We like to give you a short overview what our NEW partner LENABiosciences can achieve for you. LENA BioSciences (Atlanta, USA) offers scaffold-based technology for static and dynamic 3 D cell culture. They develop cutting edge technologies that transform cell-based assays into physiologically predictive tools.

Workflow-Series: Can Cell Culture be as good as in vivo ? Informed Consent
Part 1

Presented by Dr. Lothar Steeb, CSO, PELOBiotech

Watch on demand in German

screenMATRIX – Discover the Ideal Microenvironment for Your Application

Presented by Dejan Husman, CEO denovoMatrix, Dresden

Looking for some new ways doing 3D Cell Culture. Here you go: We like to give you a short overview what our NEW partner LENABiosciences can achieve for you.
LENA BioSciences (Atlanta, USA) offers scaffold-based technology for static and dynamic 3D cell culture. They develop cutting edge technologies that transform cell-based assays into physiologically predictive tools. Their goal: more efficient and cost-effective research for every scientist.